Pharmaceutical Policy
Mostrando 13-24 de 28 artigos, teses e dissertações.
-
13. Brazilian scientific production in the area of pharmaceutical care between 1990 and 2007 / Produção científica brasileira na área farmacêutica entre 1990 e 2007
ABSTRACT Introduction Pharmaceutical care, a concept of professional practice that can contribute to achieve positive results and minimize the negative results related to the use of drugs in society, since 2004 is included in the National Agenda of Priorities in Health Research and has been widely discussed in Brazil by researchers, policy-makers and practit
Publicado em: 2009
-
14. Estudo de utilização de medicamentos por idosos brasileiros
Elderly have a different drug use pattern when they are compared to other age groups. Excessive diagnoses and medications have been observed in the elderly and as a result, polypharmacy and inappropriate medicines use. With the increase of drugs use, the expenses with health spent on pharmaceutical care also have progressive increase, which turns more diffic
Publicado em: 2009
-
15. A percepÃÃo dos farmacÃuticos como profissionais de saÃde no SUS em Fortaleza-CE / The pharmacists perception as health professionals in primary care in the SUS in Fortaleza, CE.
The evolution of pharmaceutical extent through Public Health services and clinical context is a global tendency with repercussion on new professional practices development to support the attributions that didnât exist before. In Brazil the pharmacist role to implement the National Drug Policy and pharmaceutical practices, including pharmaceutical care, in p
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 28/05/2008
-
16. Aids, tecnologia e acesso sustentável a medicamentos: a incorporação dos anti-retrovirais no Sistema Único de Saúde / Aids, technology and sustainable access to medicine: the incorporation of antiretroviral drugs in the Single Health System
This thesis brings, in addition to concepts about the incorporation of technologies in health, an approach to the Brazilian institutional regulation, together with the description of the history and the functioning of medicines for the treatment of aids. In the second part of the work, based on a series of interviews, the courses and processes of the incorpo
Publicado em: 2008
-
17. Efeitos regionais da polÃtica nacional de medicamentos (PNM) no acesso aos remÃdios gratuitos no nordeste / National Drug Policy, Decentralization, Pharmaceutical Assistance, Essential Medicines, Access to medicines
Esta DissertaÃÃo tem como objetivo investigar a influÃncia da descentralizaÃÃo da polÃtica de medicamentos, que ocorreu com a publicaÃÃo da PolÃtica Nacional de Medicamentos (PNM), no acesso aos medicamentos gratuitos na regiÃo Nordeste. Para tanto, utilizamos o suplemento especial de SaÃde dos Microdados da PNAD de 1998 (ano antes da adoÃÃo da
Publicado em: 2008
-
18. A racionalidade da mercantilização da doença / The rationale for the commercialization of disease
A debate on a new form of relation between industry and disease is started during the 90s in English speaking countries. The new phenomenon in question was then called disease mongering, whose basic industry strategy was to expand disease boundaries in order to grow its consumer market. In the 2000s, publications widen the debate on such phenomenon and discu
Publicado em: 2008
-
19. Trabalho em vigilância sanitária: o controle sanitário da produção de medicamentos no Brasil. / The work in sanitary surveillance: the sanitary control of production of medicines in Brazil.
The work analysis in sanitary surveillance was performed due to the need of research in this field. The work in sanitary surveillance was conceived as a social practice identified in the collective practices which are developed by the State for the mediation of the social relationship production-consumption having the protection of collective health as its m
Publicado em: 2008
-
20. Detailed modelling and optmization of crystallization process / Modelagem detalhada e otimização de processos de cristalização
This work is focused on crystallization, a process widely used in industry, especially for the production of high added-value particles in pharmaceutical and fine chemistry industries. Although it is a process of established utilization, its mechanisms, modeling and the real control of its operation still require research and study. This thesis presents cons
Publicado em: 2006
-
21. Projeto de política regional de assistência farmacêutica: o exemplo do Polo Petroquímico de Camaçari / The public policy for pharmaceutical assistance projet for COPEC
O presente trabalho tem por objetivo central demonstrar a importância de um projeto regional de política de assistência farmacêutica para acidentes no trabalho, que atendam as necessidades do trabalhador acidentado e que seja provido pelo Sistema Único de Saúde, de forma a que o trabalhador não se torne refém da empresa onde sofreu o acidente, em con
Publicado em: 2005
-
22. Reforma del sector salud y la política farmacéutica en Perú
This article analyzes the Shared Pharmaceutical Management Program (PACFARM) and its relationship to pharmaceutical policy in Peru within the scope of health sector reform. Implementation of various programs for essential medicines has involved an on-going effort towards improving the supply of essential drugs to the community. However, the corresponding leg
Cadernos de Saúde Pública. Publicado em: 2002-08
-
23. La política farmacéutica nacional en Colombia y la reforma de la seguridad social: acceso y uso racional de medicamentos
Based on the new social security system in Colombia (1993), which establishes equity and mandatory care as the basis for public health care provision, the authors analyze whether the formulation and implementation of pharmaceutical policy promote accessibility, availability, and rational use of medicines, thereby contributing to equity in health. Two approac
Cadernos de Saúde Pública. Publicado em: 2002-08
-
24. Public–private interaction in pharmaceutical research
We empirically examine interaction between the public and private sectors in pharmaceutical research using qualitative data on the drug discovery process and quantitative data on the incidence of coauthorship between public and private institutions. We find evidence of significant reciprocal interaction, and reject a simple “linear” dichotomous mode
The National Academy of Sciences of the USA.